Transcriptional and post-transcriptional regulation of human MHC class II genes require the synthesis of short-lived proteins.
We have studied the stability of protein factors which control the intracellular levels of human MHC class II genes in B cells. We report that human MHC class II gene transcription and mRNA stability require the synthesis of short-lived proteins which undergo rapid intracellular turnover. We found, in fact, that the amount of MHC class II mRNA produced by human B lymphoma or B lymphoblastoid cell lines abruptly decreased upon cultivation of cells in the presence of cycloheximide, a potent inhibitor of protein synthesis. Measurements of the rate of mRNA transcription in nuclei isolated from treated cells indicated that a cycloheximide-sensitive activator protein is needed to allow MHC class II mRNA transcription initiation. Likewise, comparison of mRNA turnover rate in cells treated with actinomycin D, an inhibitor of RNA synthesis, and in cycloheximide-treated cells shows that a post-transcriptional factor is required to stabilized human MHC class II mRNA by a factor of 8- to 10-fold in B cells. These results indicate that, along with the trans- and cis-acting factors required for transcriptional control, a series of signals must exist in B cells which implement a post-transcriptional level of regulation of MHC class II gene expression in B cells.
Maffei
A
A
International Institute of Genetics and Biophysics, CNR, Napoli, Italy.
Perfetto
C
C
Ombra
N
N
Del Pozzo
G
G
Guardiola
J
J
D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D005802:Genes, MHC Class II / Q000187:drug effects; D006681:HLA-D Antigens / Q000096:biosynthesis* / Q000235:genetics; D006683:HLA-DQ Antigens / Q000096:biosynthesis / Q000235:genetics; D006207:Half-Life; D006801:Humans; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects; D012333:RNA, Messenger / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects
D006681:HLA-D Antigens; D006683:HLA-DQ Antigens; D012333:RNA, Messenger; D003513:Cycloheximide